| 摘要 |
<p>Methods and compositions that determine the expression levels of Stat4a and Stat4ß isoforms for therapeutic efficacy of anti-inflammatory treatments, assessing an individual's risk for developing inflammatory diseases including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and multiple sclerosis are disclosed.</p> |
